Linezolid Farmaprojects

Linezolid, the active ingredient in Linezolid Farmaprojects, is an oxazolidinone presented as an injectable solution for intravenous use. It treats serious infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in hospitalized patients.

GNH USA supplies Linezolid Farmaprojects as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by resistant Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective therapy for serious MRSA infections in hospitalized patients. - Vancomycin‑resistant Enterococcus (VRE) infections: offers a treatment option for infections caused by VRE. - Community‑acquired bacterial pneumonia: used to manage pneumonia caused by susceptible Gram‑positive pathogens. - Skin and soft tissue infections caused by susceptible Gram‑positive bacteria: helps resolve these infections when other agents are unsuitable.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: skin erythema or pruritus.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: numbness or tingling in extremities. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Lactic acidosis: metabolic disturbance with elevated lactate. - Optic neuropathy: visual disturbances or loss. - Myelosuppression: broader bone‑marrow suppression affecting blood cell lines.

When using Linezolid, several safety considerations are important. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Myelosuppression: perform routine complete blood counts. - Pregnancy: safety unknown; use only if potential benefit justifies the risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Linezolid can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Tyramine‑containing foods: may cause hypertensive crisis.

Moderate Interactions (Monitor Closely): - Rifampin: may reduce linezolid plasma concentrations. - Warfarin: potential increase in INR, requiring closer monitoring. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk.